AI boyfriends and diabetes drugs: when innovation leaves us lonelier

Britain’s first diabetes-delaying drug hits the NHS as AI companions seduce users with instant replies. What happens when innovation cures diseases but starves human connection?

AI boyfriends and diabetes drugs: when innovation leaves us lonelier
Photo by Philip Strong on Unsplash

The NHS just approved the world’s first drug that delays type 1 diabetes by up to three years. Millions of families will sleep easier tonight. Meanwhile, a Guardian journalist texts her AI boyfriend and realises he never argues, never forgets an anniversary, and always replies within seconds. She hates the idea. She also can’t stop messaging him.

Welcome to Britain’s innovation paradox: we are curing diseases that have stalked us for centuries, yet replacing the messy, frustrating humans who make life worth living.

The NHS delivers a miracle—while the rest of us scroll

Teplizumab, the new diabetes drug, is a genuine medical revolution. It postpones the early stages of a disease that typically strikes children and adolescents, buying them precious years before insulin dependence begins. Clinicians call it an “incredible moment.” Parents will call it a lifeline.

Yet outside the clinic, another revolution is unfolding—one that trades human friction for algorithmic comfort. AI companions, marketed as boyfriends, therapists, or even “digital soulmates,” are proliferating across British screens. They don’t judge, they don’t ghost, and they never ask for emotional labour in return. The Guardian’s experiment is telling: the journalist loathes the concept but admits the convenience is addictive. Who wouldn’t want a partner who always agrees, always listens, and never demands anything back?

The NHS is saving lives. The tech industry is selling loneliness.

Forever chemicals and forgotten seagrass: when progress forgets the planet

While Britain celebrates medical breakthroughs, its environmental innovation is stuck in reverse. Documents released this week reveal that the Ministry of Defence has been washing “forever chemicals” down drains at military bases for decades. These PFAS compounds, linked to cancer and immune disorders, persist in water supplies for generations. The MoD’s response? A call for “further investigation.” Translation: we’ll study the problem until the last affected veteran dies.

Contrast this with the voluntary seagrass protection schemes popping up along Britain’s coasts. Local communities are marking sensitive habitats with special buoys and no-anchor zones, recognising that these underwater meadows store carbon and nurture marine life. The government’s role? Cheering from the sidelines. While Australia faces a UN human rights complaint for approving fossil fuel exports, Britain’s environmental policy is a patchwork of grassroots heroism and institutional neglect.

The right to grow: when land becomes a political battleground

A quiet revolution is blooming in Britain’s unused urban spaces. The “right to grow” movement encourages communities to plant flowers or food on neglected land, improving mental health and local pride. Supporters say it’s a small act of resistance against austerity and corporate land grabs. Critics call it a distraction from systemic housing failures.

The movement’s success reveals a deeper truth: innovation isn’t just about labs and algorithms. Sometimes, it’s about reclaiming agency over the land beneath our feet. While the NHS rolls out diabetes drugs and tech firms peddle AI companions, ordinary Britons are quietly rewilding their neighbourhoods—one sunflower at a time.

What it all means: innovation without humanity is just efficiency

Britain’s innovation landscape is a study in contradictions. We’re delaying diabetes while accelerating emotional isolation. We’re protecting seagrass with buoys but poisoning water with chemicals. We’re curing diseases but outsourcing intimacy to chatbots.

The lesson isn’t that innovation is bad. It’s that innovation without a moral compass is just efficiency—and efficiency without humanity is a hollow victory. The NHS’s diabetes drug will save lives. The AI boyfriend will save time. But neither will save us from ourselves.

The real breakthroughs aren’t in labs or servers. They’re in the communities planting sunflowers on abandoned lots, the volunteers marking seagrass habitats, and the parents who will soon have three extra years with their children—years they might spend scrolling, or years they might spend truly living. The choice is ours. The technology is already here.